Magaya Promotes Matthew Fotouhi to Chief Innovation Officer to Advance Enterprise-Wide Innovation
MIAMI, Feb. 18, 2026 /PRNewswire/ — Magaya Corporation, the leading freight management platform for freight forwarders and customs brokers, today announced... Read more.
FDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant Pathogens
SANTA MARIA, Calif. and GUIPRY, France, Feb. 18, 2026 /PRNewswire/ — In a major step forward against Antimicrobial Resistance (AMR), NG Biotech, in partnership... Read more.
Ruling Protects North Carolina Homebuyers from Predatory Contracts
WASHINGTON, Feb. 18, 2026 /PRNewswire/ — The American Land Title Association (ALTA), the national trade association of the land title insurance industry,... Read more.
Nova to Participate in Upcoming Investor Conferences
REHOVOT, Israel, Feb. 18, 2026 /PRNewswire/ — Nova (NASDAQ: NVMI), a leading innovator and a key provider of advanced metrology and process control solutions... Read more.
Canada’s Workplaces Weren’t Designed for Menopause — and the Leadership Costs Are Emerging
New National Program Examines the Retention, Governance, and Legal Risks Linked to Workplace Gap TORONTO, Feb. 18, 2026 /CNW/ – Unmanaged menopause symptoms... Read more.
HUMAIN Backs xAI with $3 Billion Series E Investment Ahead of Historic SpaceX Merger
HUMAIN invested $3 billion in xAI’s Series E round just prior to its acquisition by SpaceX, positioning itself at a pivotal moment of platform-scale expansion... Read more.
V2X Awarded ATSP5 Contract to Advance Emerging Technology for the Warfighter
RESTON, Va., Feb. 18, 2026 /PRNewswire/ — V2X Inc. (NYSE: VVX) proudly announces its selection for a seat on the Advanced Technology Support Program 5 (ATSP5),... Read more.
Southeast U.S. Leader Judge PR Launches AI-Powered Marketing Service – Backed by a Creative Team with 20+ Emmy Awards – to Dominate Google, AI Searches, and Regional Markets
TAMPA, Fla., Feb. 18, 2026 /PRNewswire/ — Judge PR & Marketing announced Tuesday the launch of its proprietary AI-powered PR service, designed to elevate... Read more.
First Patients Dosed in Alphyn Biologics’ Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum
New program expands pipeline derived from Alphyn’s proprietary multi-target drug platform ANNAPOLIS, Md., Feb. 18, 2026 /PRNewswire/ — Alphyn Biologics,... Read more.
Mill Creek Announces Groundbreaking of Modera Allston
Contemporary Midrise Community to Add 240 Homes to Western Boston Neighborhood BOSTON, Feb. 18, 2026 /PRNewswire/ — Mill Creek Residential, a leading developer,... Read more.